+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Therapeutic Vaccines Market 2020-2024- Product Image

Global Therapeutic Vaccines Market 2020-2024

  • ID: 5135037
  • Report
  • July 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Advantagene Inc.
  • Aimmune Therapeutics Inc.
  • Amgen Inc.
  • Gilead Sciences Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • MORE
Global Therapeutic Vaccines Market 2020-2024

The author has been monitoring the therapeutic vaccines market and it is poised to grow by $ 3.78 bn during 2020-2024 progressing at a CAGR of 43% during the forecast period. The reports on therapeutic vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence and prevalence of diseases, strong therapeutic vaccine pipeline, and increasing funding for the development of vaccines.

The therapeutic vaccines market analysis includes type segment and geographical landscape.

The therapeutic vaccines market is segmented as below:

By Type
  • Cancer vaccines
  • Infectious diseases vaccines
  • Neurological diseases vaccines
  • Autoimmune diseases vaccines
  • Other diseases vaccines
By Geographic Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the increase in R&D activities related to novel therapeutic vaccines as one of the prime reasons driving the therapeutic vaccines market growth during the next few years. Also, initiatives to increase awareness about severe diseases and rise in number of strategic alliances will lead to sizable demand in the market.

The therapeutic vaccines market covers the following areas:
  • Therapeutic vaccines market sizing
  • Therapeutic vaccines market forecast
  • Therapeutic vaccines market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading therapeutic vaccines market vendors that include Advantagene Inc., Aimmune Therapeutics Inc., Amgen Inc., Gilead Sciences Inc., Immune Response BioPharma Inc., Inovio Pharmaceuticals Inc., Merck & Co. Inc., Novartis AG, Sanpower Group Co. Ltd., and SOTIO AS. Also, the therapeutic vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The author presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Advantagene Inc.
  • Aimmune Therapeutics Inc.
  • Amgen Inc.
  • Gilead Sciences Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Type
  • Market segments
  • Comparison by Type
  • Cancer vaccines - Market size and forecast 2019-2024
  • Infectious diseases vaccines - Market size and forecast 2019-2024
  • Neurological diseases vaccines - Market size and forecast 2019-2024
  • Autoimmune diseases vaccines - Market size and forecast 2019-2024
  • Other diseases vaccines - Market size and forecast 2019-2024
  • Market opportunity by Type
Customer landscape
  • Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Advantagene Inc.
  • Aimmune Therapeutics Inc.
  • Amgen Inc.
  • Gilead Sciences Inc.
  • Immune Response BioPharma Inc.
  • Inovio Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • Sanpower Group Co. Ltd.
  • SOTIO AS
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
Exhibit
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2019 - 2024 ($ million)
  • Global market: Year-over-year growth 2019 - 2024 (%)
  • Five forces analysis 2019 & 2024
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2019
  • Type - Market share 2019-2024 (%)
  • Comparison by Type
  • Cancer vaccines - Market size and forecast 2019-2024 ($ million)
  • Cancer vaccines - Year-over-year growth 2019-2024 (%)
  • Infectious diseases vaccines - Market size and forecast 2019-2024 ($ million)
  • Infectious diseases vaccines - Year-over-year growth 2019-2024 (%)
  • Neurological diseases vaccines - Market size and forecast 2019-2024 ($ million)
  • Neurological diseases vaccines - Year-over-year growth 2019-2024 (%)
  • Autoimmune diseases vaccines - Market size and forecast 2019-2024 ($ million)
  • Autoimmune diseases vaccines - Year-over-year growth 2019-2024 (%)
  • Other diseases vaccines - Market size and forecast 2019-2024 ($ million)
  • Other diseases vaccines - Year-over-year growth 2019-2024 (%)
  • Market opportunity by Type
  • Customer landscape
  • Market share by geography 2019-2024 (%)
  • Geographic comparison
  • North America - Market size and forecast 2019-2024 ($ million)
  • North America - Year-over-year growth 2019-2024 (%)
  • Europe - Market size and forecast 2019-2024 ($ million)
  • Europe - Year-over-year growth 2019-2024 (%)
  • Asia - Market size and forecast 2019-2024 ($ million)
  • Asia - Year-over-year growth 2019-2024 (%)
  • ROW - Market size and forecast 2019-2024 ($ million)
  • ROW - Year-over-year growth 2019-2024 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Advantagene Inc. - Overview
  • Advantagene Inc. - Product and service
  • Advantagene Inc. - Key offerings
  • Advantagene Inc. - Key customers
  • Advantagene Inc. - Segment focus
  • Aimmune Therapeutics Inc. - Overview
  • Aimmune Therapeutics Inc. - Product and service
  • Aimmune Therapeutics Inc. - Key offerings
  • Aimmune Therapeutics Inc. - Key customers
  • Aimmune Therapeutics Inc. - Segment focus
  • Amgen Inc. - Overview
  • Amgen Inc. - Business segments
  • Amgen Inc. - Key offerings
  • Amgen Inc. - Key customers
  • Amgen Inc. - Segment focus
  • Gilead Sciences Inc. - Overview
  • Gilead Sciences Inc. - Product and service
  • Gilead Sciences Inc. - Key offerings
  • Gilead Sciences Inc. - Key customers
  • Gilead Sciences Inc. - Segment focus
  • Immune Response BioPharma Inc. - Overview
  • Immune Response BioPharma Inc. - Product and service
  • Immune Response BioPharma Inc. - Key offerings
  • Immune Response BioPharma Inc. - Key customers
  • Immune Response BioPharma Inc. - Segment focus
  • Inovio Pharmaceuticals Inc. - Overview
  • Inovio Pharmaceuticals Inc. - Product and service
  • Inovio Pharmaceuticals Inc. - Key offerings
  • Inovio Pharmaceuticals Inc. - Key customers
  • Inovio Pharmaceuticals Inc. - Segment focus
  • Merck & Co. Inc. - Overview
  • Merck & Co. Inc. - Business segments
  • Merck & Co. Inc. - Key offerings
  • Merck & Co. Inc. - Key customers
  • Merck & Co. Inc. - Segment focus
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key offerings
  • Novartis AG - Key customers
  • Novartis AG - Segment focus
  • Sanpower Group Co. Ltd. - Overview
  • Sanpower Group Co. Ltd. - Product and service
  • Sanpower Group Co. Ltd. - Key offerings
  • Sanpower Group Co. Ltd. - Key customers
  • Sanpower Group Co. Ltd. - Segment focus
  • SOTIO AS - Overview
  • SOTIO AS - Product and service
  • SOTIO AS - Key offerings
  • SOTIO AS - Key customers
  • SOTIO AS - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Advantagene Inc.
  • Aimmune Therapeutics Inc.
  • Amgen Inc.
  • Gilead Sciences Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • MORE
The following companies as the key players in the global therapeutic vaccines market: Advantagene Inc., Aimmune Therapeutics Inc., Amgen Inc., Gilead Sciences Inc., Immune Response BioPharma Inc., Inovio Pharmaceuticals Inc., Merck & Co. Inc., Novartis AG, Sanpower Group Co. Ltd., and SOTIO AS.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increase in R&D activities related to novel therapeutic vaccines.'

According to the report, one of the major drivers for this market is the rising incidence and prevalence of diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • Advantagene Inc.
  • Aimmune Therapeutics Inc.
  • Amgen Inc.
  • Gilead Sciences Inc.
  • Immune Response BioPharma Inc.
  • Inovio Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Novartis AG
  • Sanpower Group Co. Ltd.
  • SOTIO AS
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll